BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is driven by the BCR::ABL fusion tyrosine kinase and progresses gradually from a chronic phase of excessive mature myeloid cell proliferation to a fatal blast crisis (BC) resembling acute myeloid leukemia (AML), which is characterized by impaired differentiation.